Your Health Matters

Actions

FDA reviewing drug that may treat postpartum depression

Posted

(KERO) — A new pill to help treat postpartum depression is now in the hands of the Food and Drug Administration (FDA).

The FDA now has until August to decide if the drug "zuranolone" should be approved, based on its effectiveness and safety. The drug is a fast-acting anti-depressant that would be taken once a day for two weeks.

The only other treatment for women suffering from postpartum depression is a one-time infusion that takes 60 hours. That treatment can cost up to $35,000.

The Centers for Disease Control and Prevention (CDC) says one in eight women who give birth will experience postpartum depression.



,

Weather

Daily Forecast

View Hourly Forecast

Day

Conditions

HI / LO

Precip

Friday

06/20/2025

Sunny

90° / 59°

0%

Saturday

06/21/2025

Sunny

82° / 59°

0%

Sunday

06/22/2025

Sunny

87° / 62°

0%

Monday

06/23/2025

Mostly Sunny

92° / 65°

0%

Tuesday

06/24/2025

Mostly Sunny

95° / 68°

0%

Wednesday

06/25/2025

Sunny

99° / 70°

0%

Thursday

06/26/2025

Sunny

100° / 70°

0%

Friday

06/27/2025

Sunny

99° / 71°

0%